Dejun Tang

611 total citations
18 papers, 461 citations indexed

About

Dejun Tang is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Dejun Tang has authored 18 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Immunology. Recurrent topics in Dejun Tang's work include Multiple Sclerosis Research Studies (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Dejun Tang is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Dejun Tang collaborates with scholars based in China, United States and Switzerland. Dejun Tang's co-authors include William Collins, Ludwig Kappos, Anthony T. Reder, Lixin Zhang-Auberson, JA Cohen, G. Francis, Paul O’Connor, François Mercier, Lee M. Jampol and Marco A. Zarbin and has published in prestigious journals such as Neurology, Ophthalmology and Annals of Oncology.

In The Last Decade

Dejun Tang

15 papers receiving 447 citations

Peers

Countries citing papers authored by Dejun Tang

Since Specialization

Citations

This map shows the geographic impact of Dejun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejun Tang more than expected).

Fields of papers citing papers by Dejun Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dejun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejun Tang. The network helps show where Dejun Tang may publish in the future.

Co-authorship network of co-authors of Dejun Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Dejun Tang. A scholar is included among the top collaborators of Dejun Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dejun Tang. Dejun Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	717MO SHR-A1921 in platinum-resistant ovarian cancer (PROC): data from a first-in-human (FIH) phase I study 2024 ·Annals of Oncology ·Zhongxiao Song, Li Chen, Qiang Dang, Dejun Tang, Tong Liu, Lei Wang, Jigang Wang, (unknown), Xu-Dong Qu, Xiao Li, Jian‐Hong Zhong, Shaozeng Zhang, Na Xing, Ye Li, Yingjie Wu, Zhenyu Lin, Zhe Zhang, Shengjia Wang	2
2	CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer 2024 ·Molecular Carcinogenesis ·Yongping Huang, (unknown), Zhengming Zhu, (unknown), Kai Huang, Dejun Tang, Jinlong Yu	0
3	A deep map transfer learning method for face recognition in an unrestricted smart city environment 2022 ·Sustainable Energy Technologies and Assessments ·Dejun Tang, Jialei Hao	2
4	Immune Score-based Molecular Subtypes and Signature Associated with Clinical Outcome in Hepatoblastoma 2021 ·Hepatitis Monthly ·Yongping Huang, (unknown), Ruiqi Liu, (unknown), Qi Dong, Dong Liu, Xiaolan Yang, Shouhua Zhang, Dejun Tang	1
5	Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes 2019 ·JNCI Cancer Spectrum ·Hajime Uno, Deborah Schrag, Dae Hyun Kim, Dejun Tang, Lü Tian, Hope S. Rugo, Lee‐Jen Wei	3
6	Discussion on Interchangeability and Adaptation in Biosimilar Development 2019 ·Statistics in Biopharmaceutical Research ·Dejun Tang, Paul Gallo	2
7	Investigation of grey matter abnormalities in multiple sclerosis patients by combined use of double inversion recovery sequences and diffusion tensor MRI at 3.0 Tesla 2018 ·Clinical Radiology ·Xuemei Han, (unknown), (unknown), (unknown), (unknown), Dejun Tang, (unknown), (unknown)	4
8	First-dose effects of fingolimod: Pooled safety data from three phase 3 studies 2014 ·Multiple Sclerosis and Related Disorders ·John Dimarco, Paul O’Connor, Jeffrey A. Cohen, Anthony T. Reder, Lixin Zhang-Auberson, Dejun Tang, William Collins, Ludwig Kappos	67
9	Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis 2013 ·Ophthalmology ·Marco A. Zarbin, Lee M. Jampol, Rama D. Jager, Anthony T. Reder, Gordon Francis, William Collins, Dejun Tang, Xiaoli Zhang	114
10	Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy 2013 ·Multiple Sclerosis Journal ·G. Francis, Ludwig Kappos, Paul O’Connor, William Collins, Dejun Tang, François Mercier, JA Cohen	107
11	A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis 2012 ·Multiple Sclerosis Journal ·Takahiko Saida, Seiji Kikuchi, Yasuto Itoyama, (unknown), (unknown), (unknown), Dejun Tang, Lixin Zhang-Auberson, Jun‐ichi Kira	65
12	A feature fusion method for feature extraction 2012 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Dejun Tang, Weishi Zhang, (unknown), Dujuan Wang	0
13	A CDIO-based teaching quality monitoring system for computer science and technology specialty at private universities 2010 ·(unknown), Dejun Tang	1
14	Exploration and Practice on the Employment-Oriented IT Professional Innovative Pedagogical Models 2008 ·Dejun Tang, (unknown), (unknown), (unknown)	1
15	Design of Robust Observer for the Switched Discrete-Time Linear System with Time Delays 2007 ·Dejun Tang	3
16	Posterior propriety and admissibility of hyperpriors in normal hierarchical models 2005 ·The Annals of Statistics ·James O. Berger, William E. Strawderman, Dejun Tang	33
17	Oxcarbazepine adjunctive therapy in infants and young children with partial seizures 2005 ·Neurology ·J. Eric Piña-Garza, (unknown), Douglas R. Nordli, (unknown), (unknown), Tracy Stites, Dejun Tang, Y. Sturm	53
18	Choice of priors for hierarchical models: Admissibility and computation 2001 ·Purdue e-Pubs (Purdue University System) ·Dejun Tang	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact